Acetylcysteine Oral and Inhalation Solution

• • Acetylcysteine solution, American Regent, 100 mg/mL, 10 mL vial, 3 count, NDC 00517-7510-03
  • Acetylcysteine solution, American Regent, 200 mg/mL, 10 mL vial, 3 count, NDC 00517-7610-03
  • Acetylcysteine solution, American Regent, 200 mg/mL, 30 mL vial, 3 count, NDC 00517-7630-03
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 10 mL vial, 3 count, NDC 63323-0693-10
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 30 mL vial, 3 count, NDC 63323-0691-30
  • Acetylcysteine solution, Fresenius Kabi, 100 mg/mL, 4 mL vial, 25 count, NDC 63323-0695-04
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 10 mL vial, 3 count, NDC 63323-0692-10
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 4 mL vial, 3 count, NDC 63323-0694-04

• • American Regent has acetylcysteine oral and inhalation solution on shortage due to manufacturing delays.
  • Fresenius Kabi has acetylcysteine oral and inhalation solution available.
  • Pfizer has acetylcysteine oral and inhalation solution on shortage due to manufacturing delays.
  • Roxane Labs discontinued acetylcysteine oral and inhalation solution in April 2014.
  • Arbor has Cetylev effervescent tablets available. These are for oral use only.

• • Cetylev oral effervescent tablet, Arbor, 2.5 gram, packet, 20 count, NDC 24338-0725-10
  • Cetylev oral effervescent tablet, Arbor, 500 mg, packet, 20 count, NDC 24338-0700-10
  • Acetylcysteine solution, American Regent, 100 mg/mL, 4 mL vial, 25 count, NDC 00517-7504-25
  • Acetylcysteine solution, American Regent, 200 mg/mL, 4 mL vial, 3 count, NDC 00517-7604-25
  • Acetylcysteine solution, Fresenius Kabi, 200 mg/mL, 30 mL vial, 3 count, NDC 63323-0690-30
  • Acetylcysteine solution, Pfizer, 100 mg/mL, 30 mL vial, 3 count, NDC 00409-3307-03
  • Acetylcysteine solution, Pfizer, 200 mg/mL, 30 mL vial, 3 count, NDC 00409-3308-03

Estimated Resupply Dates

• • American Regent has acetylcysteine solution 100 mg/mL 10 mL and 200 mg/mL 10 mL and 30 mL vials on back order and the company cannot estimate a release date.
  • Fresenius Kabi has acetylcysteine solution 200 mg/mL 4 mL and 10 mL vials on back order and the company estimates a release date of mid- to late-June 2018. The 100 mg/mL 4 mL, 10 mL and 30 mL vials are on back order and the company estimates a release date of mid- to late-June 2018.